Shorter vs longer radiation after breast cancer surgery
Part of Cancer, Skin clinical trials.
This trial compares giving breast radiation over one week versus three weeks after surgery. It aims to see whether the shorter schedule works just as well and is safe for people with certain types of early breast cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older with invasive breast cancer confirmed by biopsy (not just pre-cancer cells).
- Have had curative surgery for breast cancer (either mastectomy or breast-conserving surgery) with clear margins.
- No spread of cancer to distant organs (doctors may order scans if your risk is high).
- Be well enough to complete treatment (your health status should be in a typical range, not severely limiting).
- Be eligible to receive “adjuvant” radiation (radiation given after surgery), based on your surgery results and tumor features.
- No prior radiation to the same side chest/breast area or the mediastinum, and no remaining cancer in certain nearby lymph nodes before starting radiation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a 2-week course of radiation after breast cancer surgery works as well as a 3-week course. It may help reduce treatment time for people who have had surgery and some lymph nodes removed.
This trial compares two schedules of radiation after breast surgery in people with high-risk, node-positive breast cancer. The goal is to see whether giving radiation in 1 week or 2 weeks works well and is safe after standard treatments.
This trial compares a shorter, one-week course of radiation to the standard two-week course after a lumpectomy for early-stage breast cancer. The goal is to see if one week is just as effective and safe, making treatment more convenient.
This trial compares a shorter, more concentrated radiation schedule versus a standard shorter schedule after breast-conserving surgery. It looks at whether the treatment works well and is safe, especially for women whose lymph nodes also need radiation.
This Phase 2 trial tests a shorter, focused radiation treatment after breast surgery, either alone or with an extra targeted boost. It’s for people with low-risk breast cancer and no spread to distant organs, aiming to keep results while reducing treatment time and side effects.
This trial tests shorter radiation schedules for people with breast cancer that has spread to lymph nodes or is high-risk. It aims to find a shorter course of radiation that is just as effective after surgery.
Hear when a new Breast Cancer Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.